TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 88 filers reported holding TRILLIUM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $166,000 | -27.2% | 15,500 | 0.0% | 0.03% | -27.7% |
| Q4 2020 | $228,000 | -67.5% | 15,500 | -82.1% | 0.05% | -77.1% |
| Q2 2020 | $702,000 | -58.4% | 86,757 | -79.2% | 0.20% | -63.7% |
| Q1 2020 | $1,687,000 | -40.5% | 417,577 | -84.8% | 0.56% | -16.3% |
| Q4 2019 | $2,834,000 | – | 2,751,186 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 2,100,000 | $646,000 | 0.05% |
| Matrix Capital Management Company, LP | 2,288,560 | $704,000 | 0.02% |
| Tekla Capital Management LLC | 446,099 | $137,000 | 0.01% |
| Realta Investment Advisors | 26,000 | $7,000 | 0.00% |
| Virtu Financial LLC | 34,991 | $11,000 | 0.00% |
| Baker Brothers Advisors | 505,262 | $155,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 20,044 | $6,000 | 0.00% |
| MORGAN STANLEY | 1,160,098 | $356,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 18,333 | $6,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 102,725 | $31,000 | 0.00% |